Cargando…

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency

The Myc oncogene regulates the expression of multiple components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, Pol III, and rDNA1,2. An outstanding question is whether and how increasing the cellular protein synthesis capacity can affect the mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Barna, Maria, Pusic, Aya, Zollo, Ornella, Costa, Maria, Kondrashov, Nadya, Rego, Eduardo, Rao, Pulivarthi H, Ruggero, Davide
Formato: Texto
Lenguaje:English
Publicado: 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880952/
https://www.ncbi.nlm.nih.gov/pubmed/19011615
http://dx.doi.org/10.1038/nature07449
_version_ 1782182059787157504
author Barna, Maria
Pusic, Aya
Zollo, Ornella
Costa, Maria
Kondrashov, Nadya
Rego, Eduardo
Rao, Pulivarthi H
Ruggero, Davide
author_facet Barna, Maria
Pusic, Aya
Zollo, Ornella
Costa, Maria
Kondrashov, Nadya
Rego, Eduardo
Rao, Pulivarthi H
Ruggero, Davide
author_sort Barna, Maria
collection PubMed
description The Myc oncogene regulates the expression of multiple components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, Pol III, and rDNA1,2. An outstanding question is whether and how increasing the cellular protein synthesis capacity can affect the multi-step process leading to cancer. We utilized ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in Eμ–Myc/+ transgenic mice to normal levels and show that in this context Myc's oncogenic potential is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a novel paradigm that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation employed to regulate the expression of selective mRNAs. We show that an aberrant increase in cap-dependent translation downstream Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site (IRES)-dependent translation required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic-specific expression of the endogenous IRES-dependent form of Cdk11 (p58-PITSLRE)3-5, which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in Eμ–Myc/+ mice. When accurate translational control is re-established in Eμ–Myc/+ mice, genome instability is suppressed. Our findings reveal how perturbations in translational control provide a highly specific outcome on gene expression, genome stability, and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post-genomic level.
format Text
id pubmed-2880952
institution National Center for Biotechnology Information
language English
publishDate 2008
record_format MEDLINE/PubMed
spelling pubmed-28809522010-06-04 Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency Barna, Maria Pusic, Aya Zollo, Ornella Costa, Maria Kondrashov, Nadya Rego, Eduardo Rao, Pulivarthi H Ruggero, Davide Nature Article The Myc oncogene regulates the expression of multiple components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, Pol III, and rDNA1,2. An outstanding question is whether and how increasing the cellular protein synthesis capacity can affect the multi-step process leading to cancer. We utilized ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in Eμ–Myc/+ transgenic mice to normal levels and show that in this context Myc's oncogenic potential is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a novel paradigm that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation employed to regulate the expression of selective mRNAs. We show that an aberrant increase in cap-dependent translation downstream Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site (IRES)-dependent translation required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic-specific expression of the endogenous IRES-dependent form of Cdk11 (p58-PITSLRE)3-5, which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in Eμ–Myc/+ mice. When accurate translational control is re-established in Eμ–Myc/+ mice, genome instability is suppressed. Our findings reveal how perturbations in translational control provide a highly specific outcome on gene expression, genome stability, and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post-genomic level. 2008-11-16 2008-12-18 /pmc/articles/PMC2880952/ /pubmed/19011615 http://dx.doi.org/10.1038/nature07449 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Barna, Maria
Pusic, Aya
Zollo, Ornella
Costa, Maria
Kondrashov, Nadya
Rego, Eduardo
Rao, Pulivarthi H
Ruggero, Davide
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
title Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
title_full Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
title_fullStr Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
title_full_unstemmed Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
title_short Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
title_sort suppression of myc oncogenic activity by ribosomal protein haploinsufficiency
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2880952/
https://www.ncbi.nlm.nih.gov/pubmed/19011615
http://dx.doi.org/10.1038/nature07449
work_keys_str_mv AT barnamaria suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT pusicaya suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT zolloornella suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT costamaria suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT kondrashovnadya suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT regoeduardo suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT raopulivarthih suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency
AT ruggerodavide suppressionofmyconcogenicactivitybyribosomalproteinhaploinsufficiency